ContraFect Earns Sell Rating from Analysts at StockNews.com
Slightly above 67% of ContraFect Corp's investor base is looking to short. The analysis of current outlook of investing in ContraFect Corp suggests that many traders are alarmed regarding ContraFect Corp's prospects. ContraFect Corp's investing sentiment can be driven by a variety of factors including economic data, ContraFect Corp's earnings reports, geopolitical events, and overall market trends.
ContraFect |
StockNews.com assumed coverage on shares of ContraFect in a report released on Thursday morning. The firm issued a sell rating on the biotechnology companys stock. ContraFect Trading Down 28.0 percent Shares of NASDAQ CFRX opened at 0.05 on Thursday. ContraFect has a 12-month low of 0.04 and a 12-month high of
Read at thelincolnianonline.com
 |
ContraFect Corp Fundamental Analysis
We analyze ContraFect Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ContraFect Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ContraFect Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
ContraFect Corp is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
ContraFect Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ContraFect Corp stock to make a market-neutral strategy. Peer analysis of ContraFect Corp could also be used in its relative valuation, which is a method of valuing ContraFect Corp by comparing valuation metrics with similar companies.
Peers
ContraFect Corp Related Equities
| CNSP | Cns Pharmaceuticals | 27.27 | ||||
| UNCY | Unicycive Therapeutics | 5.36 | ||||
| DRMA | Dermata Therapeutics | 5.31 | ||||
| REVB | Revelation Biosciences | 2.88 | ||||
| VRAX | Virax Biolabs | 1.06 | ||||
| PALI | Palisade Bio | 0.97 | ||||
| ALLR | Allarity Therapeutics | 2.97 | ||||
| QNRX | Quoin Pharmaceuticals | 6.06 | ||||
| WINT | Windtree Therapeutics | 6.67 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in ContraFect Stock
If you are still planning to invest in ContraFect Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ContraFect Corp's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |